Skip to main content
. 2012 Oct 12;63(4):327–333. doi: 10.4097/kjae.2012.63.4.327

Fig. 2.

Fig. 2

Consecutive remifentanil effect-site concentrations in head holder pinning for EC50 determination. In the absence of either heart rate or MAP increasing > 20% (success), the effect-site concentration given to the next patient was decreased. Otherwise referred to as a failure, the effect-site concentration administered to the next patient was increased.